Contact l Sitemap

home industries issues reasearch weblog press

Home  » Industries » Pharmaceuticals

Pharmaceuticals : Displaying 21-30 of 33


Court to Hear Challenge to Myriadís Human Gene Patent
by Pratap ChatterjeeCorpWatch Blog
July 19th, 2012
Should a private company be allowed to patent isolated human genes? A lawsuit to be heard Friday pits Myriad Genetics of Utah against the American Civil Liberties Union (ACLU). Myriad wants to be the exclusive U.S. commercial provider of genetic screening tests for breast cancer or ovarian cancer.

Fake Drug Plague or Pharmaceutical Industry Attack on Generics?
by Pratap ChatterjeeCorpWatch Blog
June 13th, 2012
Are Africa and South East Asia just suffering from a deluge of fake medicines that is causing disease resistance to rise? Or are they also suffering from a deluge of poorly informed media articles, encouraged by the pharmaceutical industry that wants to make war on generic drugs?

Fighting Malaria: Big Pharma or Better Aid Coordination?
by Pratap ChatterjeeCorpWatch Blog
May 2nd, 2012
Why donít drug companies invest enough money in treating malaria and tuberculosis? A recent study published in the Lancet magazine estimates that 1,238,000 people died from malaria in 2010. Surely a wonder drug that stops these diseases would be wildly profitable?

Johnson & Johnson Fined $1.2 Billion for Drug Labeling Failure
by Pratap ChatterjeeCorpWatch Blog
April 12th, 2012
Johnson & Johnson has been fined $1.2 billion in Arkansas over the sales of Risperdal, an antipsychotic drug. A circuit judge ruled that the company did not warn patients that the drug places elderly patients with dementia at an increased risk of major weight gain, possible diabetes and potential death.

Deadly Blow to Death Penalty Drugs
by Pratap ChatterjeeCorpWatch Blog
March 28th, 2012
U.S. imports of sodium thiopental have been banned by a federal judge because of the poor quality of imports. The ruling has struck a serious blow against the death penalty because of the key role the drug plays in lethal injections. Not surprisingly, the state of Texas is furious.

India Ends Bayer Monopoly, Helps Slash Prices for Life-Saving Drugs
by Pratap ChatterjeeCorpWatch Blog
March 12th, 2012
The decision by PH Kurian, the controller general of patents, designs and trademarks in India, to allow a local company to manufacture Sorafenib, a drug used to treat advanced kidney cancer and liver cancer, is a welcome move that supports the access of poor people to cheap life-saving drugs.

Grey Market Drugs: Profiting from Poorly Managed U.S. Health Care
by Terry J. AllenSpecial to CorpWatch
January 22nd, 2012
Scalpers are doing a booming business in key medical drugs by taking advantage of U.S. patients and hospitals when they are desperate for supplies from the poorly regulated $46 billion global contract-manufacturing industry.

Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug
by Shelley JofreSpecial to Corp Watch
July 30th, 2007
GlaxoSmithKline provides research funding to doctors who write favorable opinions of depression drugs for children, despite evidence from clinical trials that the medication can cause anger and even suicide.

Merck's Murky Dealings: HPV Vaccine Lobby Backfires
by Terry J. AllenSpecial to CorpWatch
March 7th, 2007
Merck's lobbying campaign for mandatory vaccination of school girls provided funding for a prominent women's non-profit. The ensuing uproar has created a backlash against the pharmaceutical giant.

Exporting Cures, Importing Misery
by By Stan CoxAlterNet
January 19th, 2005
The Kazipally industrial area Ė once good farm country Ė now accounts for more than one-third of India's pharmaceutical industry, meaning skyrocketing rates of cancer, heart disease and birth defects for its residents.